Modivcare Inc Intrinsic Value Calculation – Modivcare to Showcase Innovative Healthcare Solutions at J.P. Morgan Healthcare Conference

☀️Trending News

Modivcare Inc ($NASDAQ:MODV), a leading medical technology and healthcare services provider, has been invited to speak at the 42nd Annual J.P. Morgan Healthcare Conference. It will be an important opportunity for Modivcare to showcase its innovative healthcare solutions and services. Modivcare Inc is an American publicly traded company offering a wide range of medical technology and healthcare services. It focuses on developing cutting-edge products and services to improve patient care and outcomes. Its products and services are designed to make healthcare more accessible, affordable, and efficient. The company has established a strong presence in the U.S. and global markets, providing solutions to hospitals, clinics, outpatient centers, government agencies, managed care providers, and other healthcare facilities.

Modivcare also offers consulting services, helping healthcare organizations make informed decisions about their operations. These include investors, executives from the biotechnology, medical device, pharmaceutical, and health services industries, as well as venture capitalists, private equity firms, and insurance companies. This is an exciting opportunity for Modivcare to demonstrate its commitment to improving patient outcomes through cutting-edge technology and services. The J.P. Morgan Healthcare Conference is an important event for Modivcare Inc as it provides a platform to showcase its innovative healthcare solutions and services in front of some of the most influential people in the industry. By attending the event, Modivcare will have the chance to demonstrate why it is one of the world’s leading providers of medical technology and healthcare services.

Price History

Friday saw MODIVCARE INC‘s shares take a slight dip in the market, with their stock opening at $44.5 and closing at $44.0, 1.8% lower than the previous closing price of 44.8. MODIVCARE INC has a history of bringing to market cutting-edge healthcare solutions, and this conference is set to be no exception. They will be exhibiting a number of products and services, designed to revolutionize the way healthcare is delivered. With their advanced offerings, they are looking to make a name for themselves in an increasingly competitive landscape.

By displaying their range of innovative healthcare solutions at the J.P. Morgan Healthcare Conference, MODIVCARE INC will be hoping to make a strong impression on investors and potential customers alike. As the healthcare industry continues to evolve and advance, their products and services may be just what the market needs to stay ahead of the curve. Live Quote…

About the Company

Income Snapshot

Below shows the total revenue, net income and net margin for Modivcare Inc. More…

Cash Flow Snapshot

Below shows the cash from operations, investing and financing for Modivcare Inc. More…

Balance Sheet Snapshot

Below shows the total assets, liabilities and book value per share for Modivcare Inc. More…

Key Ratios Snapshot

Some of the financial key ratios for Modivcare Inc are shown below. More…

Analysis – Modivcare Inc Intrinsic Value Calculation

At GoodWhale, we have performed an analysis of MODIVCARE INC‘s fundamentals. Our proprietary Valuation Line has calculated the intrinsic value of its share to be around $143.7, while the current market price is at $44.0. This means that MODIVCARE INC stock is currently undervalued by 69.4%. We believe that this presents a good opportunity for investors looking for long-term returns. More…

Peers

In the healthcare industry, there is intense competition between ModivCare Inc and its competitors: Humana AB, Mednax Inc, and Hanger Inc. These companies are all vying for a share of the market, and each has its own unique strengths and weaknesses. Humana AB is a large, international company that offers a wide range of services. Mednax Inc is a smaller company that specializes in maternal and child health. Hanger Inc is a publicly traded company that focuses on orthopedics.

– Humana AB ($LTS:0RF7)

Humana AB is a Swedish health insurance company with a market capitalization of 2.04 billion as of 2022. The company has a return on equity of 10.21%. Humana AB provides health insurance products and services to individuals, families, and businesses in Sweden. The company offers a range of health insurance products, including hospital, medical, and dental insurance. Humana AB also provides health and wellness services, such as health coaching and wellness programs.

– Mednax Inc ($NYSE:MD)

Mednax, Inc. is a national provider of maternal-fetal, newborn and pediatric clinical and anesthesia services. The Company operates through three segments: Physician Services, Ancillary Services and Other Services. The Company’s physician services include clinical care provided by its affiliated physicians and other clinicians to expectant mothers, newborn infants and pediatric patients in connection with their mothers’ pregnancies and deliveries, and neonatal intensive care unit (NICU) care. Ancillary services include diagnostic testing, pharmacy and ambulatory surgery center (ASC) operations. The Company’s other services include remote patient monitoring, patient engagement solutions and population health management services.

Summary

MODIVCARE Inc. is a healthcare technology company that provides a platform for healthcare professionals and their patients. Recently, the company announced that it will be presenting at the 42nd annual J.P. Morgan Healthcare Conference. The conference will provide investors with insights on MODIVCARE’s cutting-edge technology and innovative solutions for healthcare professionals and their patients. During the event, investors will gain an understanding of the company’s strategies for growth and development.

Additionally, investors can learn more about MODIVCARE’s financial performance, including key metrics such as revenue, profitability, debt, and valuation. At the conference, investors will be able to gain insights on the competitive landscape in healthcare technology, as well as the potential for MODIVCARE to capture market share and expand its presence. Overall, the J.P. Morgan Healthcare Conference is an ideal opportunity for investors to gain a deeper understanding of MODIVCARE and make informed investing decisions.